Study Stopped
Research question was integrated in other study protocol
Steroid-induced Reduction of Surgical Stress Study
STRESS
Reduction of the Cardiac Proapoptotic Stress Response by Dexamethasone in Patients Undergoing Coronary Artery Bypass Grafting Surgery
1 other identifier
interventional
N/A
1 country
1
Brief Summary
The stress response as induced by myocardial cellular damage during cardiac surgery may lead to myocardial stunning and apoptosis, and could therefore impair postoperative patient recovery. Surgical trauma typically induces the liberation of cytokines. Some of these cytokines are strongly associated with the initiation of intracellular proapoptotic pathways through activation of tyrosine kinases and integrins. The latter are known for their deteriorating effects on cardiac function and are strongly involved in cardiac remodeling. Dexamethasone is typically administered prior to cardiac surgery in order to especially reduce the release of proinflammatory cytokines. It has however never been investigated whether this additionally reduces proapoptotic signaling in the human heart, thereby eliminating risk factors for the induction of cardiac dysfunction. In the present study, the investigators therefore aim to investigate whether dexamethasone inhibits proapoptotic pathways in patients undergoing cardiac surgery. Furthermore, the investigators would like to elucidate whether this proposed effect of dexamethasone is related to the reduction of the stress response in the heart or indirectly by suppression of cytokine release. For this purpose the investigators will obtain cardiac biopsies and plasma from patients, who are randomly assigned to placebo or dexamethasone treatment and undergo on and off-pump coronary artery bypass grafting (CABG) surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Dec 2008
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2008
CompletedFirst Submitted
Initial submission to the registry
December 11, 2008
CompletedFirst Posted
Study publicly available on registry
December 12, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2011
CompletedDecember 17, 2014
December 1, 2014
2 years
December 11, 2008
December 16, 2014
Conditions
Outcome Measures
Primary Outcomes (1)
Expression of p38 in cultured cells and cardiac tissue
One week
Secondary Outcomes (1)
Pro-apoptotic signaling, precursor peptides of ANP (proANP), vasopressin (Copeptin), proET-1 and Adrenomedullin (proADM). Age, gender, length, body weight, hematocrit, Hb, leukocytes, surgery time, clamp time, CPB time
One week
Study Arms (2)
1
ACTIVE COMPARATORHigh dose bolus of dexamethasone before surgery
2
PLACEBO COMPARATORPlacebo control
Interventions
Eligibility Criteria
You may qualify if:
- Patients undergoing coronary artery bypass surgery (CABG)
- Age 18-75 years
- Informed consent
You may not qualify if:
- Re-operations and emergency operations
- Patient with anemia (Hb \< 5.0)
- Emergency operation
- Patients receiving blood transfusions \< 3 months before operation
- Insulin depended diabetes mellitus
- Hepatic or renal failure
- Pregnancy
- Use of steroids
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
VU University Medical Center
Amsterdam, 1081 HV, Netherlands
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jan R. de Jong, MD
Amsterdam UMC, location VUmc
- STUDY CHAIR
dr. Christa Boer, PhD
Amsterdam UMC, location VUmc
- PRINCIPAL INVESTIGATOR
dr. Everaldo M. Redout, PhD
Amsterdam UMC, location VUmc
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prof.dr. C. Boer
Study Record Dates
First Submitted
December 11, 2008
First Posted
December 12, 2008
Study Start
December 1, 2008
Primary Completion
December 1, 2010
Study Completion
June 1, 2011
Last Updated
December 17, 2014
Record last verified: 2014-12